Twist Bioscience (TWST) Payables (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Payables data on file, last reported at $14.7 million in Q1 2026.

• Payables for Q1 2026 came in at $14.7 million, up 82.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.7 million (up 82.09% YoY), and the FY2025 annual result was $11.1 million, up 580.61% from the prior year.
• Payables climbed to $14.7 million in Q1 2026 per TWST's latest filing, from $12.5 million in the prior quarter.
• Over five years, Payables peaked at $21.0 million in Q2 2022 and troughed at $1.6 million in Q3 2024.
• A 5-year average of $12.2 million and a median of $12.1 million in 2023 frame the typical range for Payables.
• The sharpest annual moves came in 2023 and 2025: Payables tumbled 53.98% in 2023, then surged 580.61% in 2025.
• A 5-year view of Payables shows it stood at $20.1 million in 2022, then plunged by 53.98% to $9.3 million in 2023, then fell by 18.94% to $7.5 million in 2024, then jumped by 66.51% to $12.5 million in 2025, then gained by 17.52% to $14.7 million in 2026.
• Business Quant data shows TWST's Payables at $14.7 million in Q1 2026, $12.5 million in Q4 2025, and $11.1 million in Q3 2025.